Market View 11th August, 2026

View on market: Volatility persists, eagerly searching for growth:

Asian markets traded mostly lower, supported by a lower finish on Wall Street in the previous session. And investors remained cautious due to continued uncertainty over US-Iran negotiations and elevated crude oil prices. Japan closed for today and, while Australia traded slightly lower. US markets ended lower as investors remained focused on developments between the US and Iran and the situation around the Strait of Hormuz. The S&P 500 was largely unchanged, while the Nasdaq and Dow traded slightly lower. Investors are waiting for more clarity on geopolitical tensions and their possible impact on oil prices and global markets. Indian markets ended marginally higher in the previous session. The Nifty and Sensex gained slightly, supported mainly by Bajaj Finance and Titan. However, selling pressure in SBI and Reliance Industries limited the overall market gains. Overall, markets remained cautious as investors monitored global geopolitical developments and crude oil movements.

Key Quarterly Results

ALEMBICLTD, AMRUTANJAN, ASHIANA, ASHOKA, BATAINDIA, BNAGROCHEM, CEINSYS, DAMCAPITAL, DELTACORP, DISHTV, EPACK, FINCABLES, FOSECOIND, HARSHA, IFCI, JNKINDIA, JSWDULUX, JYOTIRES, KPIGREEN, KUSUMGAR, LANDMARK, LLOYDSENT, MANAPPURAM, MANINDS, MRF, NBCC, PIIND, RVNL, SIEMENS, SKFINDUS, SURYAROSNI, UNICHEMLAB, VIDYAWIRES, ZYDUSLIFE.

Economic Calendar:

• USD: CPI on 12^th August 2026.
• IND: CPI on 12^th August 2026.
• USD: PPI and Continuing & Initial Jobless Claim Data on 13^th August 2026.
• IND: WPI and Passenger Vehicle Sales Data and Foreign Reserves Data and Bank Loan & Deposit Growth Rate on 14^th August 2026.

BROKERAGE RADAR:

GOLDMAN SACHS ON GLAND PHARMA:

Target ₹2125 Earlier Target ₹1875 Recommendation Sell, Q1 above: Margin performance healthy, Cenexi turnaround progressing, albeit still early, Hike FY27-29E EPS estimates by 8% to 10% to factor in the Q1 beat, revised guidance/business outlook by management, Remain Sell on valuation.

JEFFERIES ON PNB:

Target ₹130 Recommendation Accumulate, MD & CEO of PNB highlighted that the bank is focusing on quality of loan growth, Focusing through direct origination at fair-yields, instead of buyout or low-yielding corp loans, NIMs can expand from Q1 levels & bank sees ROA of 1-1.1% over FY27-28, ECL can be a slight drag, and we watch out for the start of next wage negotiations, See 13% Cagr in loans & ROA of 0.9% in FY27.

MACQUARIE ON ZYDUS LIFE:

Target ₹1285 Earlier Target ₹1260 Recommendation Outperform, Near-term catalysts support long-term growth, Recent capital allocation towards new businesses and assess the outlook for its existing segments, Believe MedTech, Specialty, CDMO and D2C build-out is underappreciated, This is supported by strong teams and disciplined execution, Domestic business, generics exports well positioned to drive near-tem earnings growth while newer businesses build out.

MORGAN STANLEY ON BHARAT FORGE:

Target ₹2469 Earlier Target ₹2233 Recommendation Overweight, Weak Quarter, an Opportunity to Add, Q1 was hit by issues that are transitory, Highlights of the quarter: improvement in defence margins and increase in capex to capture upcoming manufacturing opportunities, FY28e P/E is 42x; the auto supplier average stands at 38x while Industrial peers trade at ~49x.

International Markets:

U.S & Europe:

*As per 11^th August.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs

View on market: Volatility persists, eagerly searching for growth

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

1. InCred Markets Limited (“the Company”), Formerly known as Elite Wealth Limited (The company is Wholly Owned Subsidiary of InCred Capital Financial Services Limited) does/ does not do business with companies covered in its research reports. Investors should be aware that the Company may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by the Company are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)Disclosure AppendixAnalyst Certification (For Reports)Vindhyachal Prasad, InCred Markets Limited, vindhyachal@elitestock.comThe analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in the Company.As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
   1. All of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
   2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

   Research Excerpts

   This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

   Company-Specific Disclosures

   Important disclosures, including price charts, are available and all InCred Markets Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. The Company may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

   Options related research:

   If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

   Other Disclosures

   All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

   Ownership and material conflicts of interest Disclosure

   InCred Markets Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of the Company. Analyst as officer or director: The Company’s policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

   Country Specific Disclosures

   India – For private circulation only, not for sale. Legal

   Entities Disclosures

   InCred Markets Limited (Formerly known as Elite Wealth Limited) (IML henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

   The Company discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

   1. Reports
   2. IML or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
   3. IML or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
   4. IML or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
   5. Compensation
   6. IML  or its associates have not received any compensation from the subject company in the past twelve months;
   7. IML or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
   8. IML or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
   9. IML or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
   10. IML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
   11. In respect of Public Appearances
   12. IML or its associates have not received any compensation from the subject company in the past twelve months;
   13. The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by IML